RYGB and the Gastric Adipose Axis

ClinicalTrials.gov ID: NCT01474785

Public ClinicalTrials.gov record NCT01474785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 25, 2026, 1:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RYGB Improves Metabolism by Interrupting the Gastric Adipose Tissue Axis

Study identification

NCT ID: NCT01474785
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Vanderbilt University; Other
Enrollment: 49 participants

Conditions and interventions

Conditions

Obesity

Interventions

human ghrelin Drug
very low calorie diet Other
Hyperinsulinemic/Euglycemic Clamp Procedure

Drug · Other · Procedure

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2011
Primary completion: Jun 30, 2015
Completion: Jun 30, 2015
Last update posted: May 20, 2018

2012 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Vanderbilt University Medical Center	Nashville	Tennessee	34232	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01474785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 20, 2018 · Synced Jul 25, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01474785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →